RxDoctor Payments Data

Bradley Seaman, MD

Otolaryngology · Overland Park, KSNPI 1437310307

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,555 of the $8,383 with a category attached, or 66.3%. 28 manufacturers reported payments, led by Intersect ENT, Inc. at 45.4% of the total. Reporting peaked in 2019 at $4,270 and has fallen 84.3% since, to $672 in 2025.

$8,383in general payments, 2019–2025

Across 161 payments — averaging $52.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$4K
  • Aerin Medical Inc.$2K
  • Stryker$540
  • GSK$454
  • Optinose US, Inc.$427
  • Regeneron Healthcare Solutions, Inc.$300
  • plus $1K from 22 others

What the payments were for

  • Travel & lodging$2,73033%
  • Food & beverage$5,55566%
  • Education$981%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,383 in reported general payments places this provider in the 85th percentile of 87 otolaryngology providers in Kansas.

See all otolaryngology providers in Kansas

Medicare billing

Part B allowed, 2024
$174,859
Medicare patients
384
Services billed
1,587

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$41,164
Fluticasone Propionate181$3,839
Azelastine Hcl135$3,438
Ipratropium Bromide76$1,866
Famotidine110$1,512
Omeprazole53$1,033
Mupirocin94$614
Dexamethasone Sodium Phosphate11$371
Doxycycline Hyclate43$361
Montelukast Sodium16$326
Pantoprazole Sodium21$324
Levocetirizine Dihydrochloride13$295
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav33$273
Ciprofloxacin Hcl15$268
Ofloxacin16$263

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →